2008
DOI: 10.1182/blood-2007-09-115022
|View full text |Cite
|
Sign up to set email alerts
|

Efficient transduction of pigtailed macaque hematopoietic repopulating cells with HIV-based lentiviral vectors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
91
1

Year Published

2009
2009
2017
2017

Publication Types

Select...
5
3

Relationship

3
5

Authors

Journals

citations
Cited by 61 publications
(96 citation statements)
references
References 32 publications
4
91
1
Order By: Relevance
“…For in vivo studies, cells were costained with a human/NHPspecific antibody (anti-human CD45 PerCP and anti-primate CD45-BV786 or anti-human CD45 APC Cy7), a mouse CD45-specific antibody (anti-mouse CD45 FITC, eBiosciences clone 30-F11, catalog no. enriched from pigtail macaque BM as previously described (56). Lentivirus vector production.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…For in vivo studies, cells were costained with a human/NHPspecific antibody (anti-human CD45 PerCP and anti-primate CD45-BV786 or anti-human CD45 APC Cy7), a mouse CD45-specific antibody (anti-mouse CD45 FITC, eBiosciences clone 30-F11, catalog no. enriched from pigtail macaque BM as previously described (56). Lentivirus vector production.…”
Section: Methodsmentioning
confidence: 99%
“…After 12 days, plates were scored for hematopoietic colony phenotypes (CFU-E, CFU-M CFU-GM, CFU-GEMM) under a light microscope. Individual colonies from each experiment were randomly picked for Wright-Giemsa staining of cytospin samples and, in some studies, for analysis of proviral integration by PCR assay (56).…”
Section: Methodsmentioning
confidence: 99%
“…Hematopoietic recovery and long-term gene marking prior to MGMT P140K -mediated in vivo selection has been previously described for monkeys J02043, J02370, and T04228 (14). Monkey M05189, which received cells transduced with a tricistronic lentivirus vector containing an anti-HIV transgene (C46), MGMT P140K , and GFP, recovered complete blood counts, with normal engraftment kinetics (14) reaching an absolute neutrophil count (ANC) of more than 500 neutrophils per μl by day 17 (24).…”
Section: Efficient Mgmt P140k -Mediated In Vivo Selection and Chemoprmentioning
confidence: 99%
“…Successful HSC gene therapy has been unequivocally demonstrated for patients with X-linked SCID (SCID-X1) (4), adenosine deaminase deficient SCID (5), X-linked chronic granulomatous disease (X-CGD) (6), and adrenoleukodystrophy (ALD) (7). Numerous advances in transduction protocols, including transduction on fibronectin fragment CH-296 (8), the use of multiple cytokines (9,10), and the use of different vector pseudotypes (11)(12)(13), have contributed to gene transfer levels of 20%-30% in clinically relevant nonhuman primates (14). Even with the gene marking levels (defined as the percentage or fraction of genetically modified cells) achieved clinically ranging from approximately 9%-15% in peripheral blood with reduced-intensity busulfan (6) and high-intensity cyclophosphamide and busulfan (7) and levels in the nonhuman primate ranging from 20%-30% in peripheral blood with total body irradiation (TBI) (14), for numerous clinical applications gene marking levels will still likely be below therapeutic thresholds (for review see ref.…”
Section: Introductionmentioning
confidence: 99%
“…Lentiviral vector integrates into the host cell genome, and the foreign gene can be expressed stably and constitutively (24). It can also infect dividing and non-dividing cells, such as nerve cells, hematopoietic stem cells, and liver cells (25). The probability of lentiviral vector gene recombination is higher, the exogenous recombinant is stable, not easy to lose, and easy to be amplified in large amounts (26).…”
Section: Discussionmentioning
confidence: 99%